We investigated the influence of Astaxanthin (Ax), which exhibits strong antioxidant activity, 23 during in vitro growth (IVG) on the developmental competence of oocytes and 24 steroidogenesis of granulosa cells derived from early antral follicles. Bovine oocyte-25 cumulus-granulosa complexes collected from early antral follicles were cultured for 12 days 26 in the presence (500 µM) or absence (control) of Ax. Viability of oocytes and antrum 27 formation in granulosa cell layer during IVG culture were greater in the presence of Ax than 28 in its absence (P<0.05). Regardless of Ax treatment, estradiol-17β production increased 29 during IVG culture; however, progesterone production was significantly lower in the 30 presence of Ax than in its absence (P<0.05). Reactive oxygen species levels were lower in 31 Ax-treated oocytes than in controls after IVG (P<0.05). Although the nuclear maturation and 32 cleavage rates did not differ regardless of Ax treatment, Ax treatment led to weaker cathepsin 33 B activity in oocytes and better blastocyst rates than those in controls (P<0.05). Accordingly, 34 Ax treatment during IVG increased total cell numbers in blastocysts (P<0.05). These results 35 indicate that Ax supplementation to IVG medium improves the quality of bovine oocytes due 36 to its antioxidative effects on growing oocytes and its suppression of the luteinization of 37 granulosa cells. 38 39 Additional Keywords: astaxanthin, cathepsin B, early antral follicle, IVG, ROS generation 40 41 42 43 Assisted reproductive technologies (ARTs) including in vitro maturation (IVM), the in vitro 44 fertilization (IVF) of oocytes, and in vitro culture (IVC) for the production of transferable 45 embryos are uniquely desirable for improving the breeding of animals and also for the 46 perpetuation programs of wild and endangered species. Moreover, the isolation and IVC of 47 ovarian follicles to obtain fertilizable oocytes and further embryo development have been 48 regarded as a propitious strategy to strive against infertility issues (Hansen 2014; 49 Szamatowicz 2016; Kushnir et al. 2017).
Introduction
submitted them to IVM. Briefly, cumulus-oocyte complexes (COCs) were incubated in 50-151 μL droplets of IVM medium (approximately 10 COCs per droplet) and were then covered 152 with paraffin oil for 22 h at 39°C in a humidified atmosphere with 5% CO2 (Takahashi and 153 Kanagawa 1998a). COCs derived from OCGCs after IVG were cultured individually in 154 microwell plates (Mini Trays 163118; NUNC, Roskilde, Denmark) filled with 6 mL of 155 maturation medium (Nagano et al. 2013) . Maturation medium consisted of HEPES-buffered 156 TCM199 supplemented with 0.2 mM sodium pyruvate, 0.02 units/mL FSH (from the porcine 100-µL droplet (approximately 10 COCs per droplet) of modified Brackett and Oliphant 173 isotonic medium (Brackett and Oliphant 1975) containing 3 mg/mL fatty acid-free BSA and 174 2.5 mM theophylline (Takahashi and First 1992) at 39°C for 18 h in a humidified atmosphere 175 of 5% CO2, 5% O2, and 90% N2. IVC of inseminated oocytes (presumptive zygotes) was 176 performed as previously described (Takahashi and Kanagawa 1998b) . Briefly, after an 177 incubation with sperm, presumptive zygotes were freed from cumulus cells by vortexing and 178 washing three times in culture medium. Cumulus-free zygotes were cultured for 6 days in 179 30-µL droplets (approximately 20 zygotes per droplet) of culture medium at 39 °C under 5% 180 CO2, 5% O2, and 90% N2. Culture medium consisted of modified synthetic oviduct fluid 181 containing 1 mM glutamine, 12 essential amino acids for basal medium Eagle, seven non-182 essential amino acids for minimum essential medium, 10 µg/mL insulin, and 5 mM glycine, Effects of the Ax treatment on OCGC growth parameters after IVG. 283 The results for the growth parameters of OCGCs before and after the IVG culture in the 284 presence and absence of the Ax treatment are shown in Fig. 4 . OCGC viability decreased in 285 a day-dependent manner in both groups. However, OCGC viability during the IVG culture 286 was significantly higher in the Ax-treated group than in the control (P < 0.05). The percentage 287 of antrum-forming OCGCs increased in a day-dependent manner in both groups and was 288 significantly higher in the Ax-treated group than in the control (P < 0.05). The diameters of 289 oocytes were significantly larger (P < 0.05) than those before the IVG culture in both groups; 290 however, no significant difference was observed in oocyte diameters between the Ax and 291 control groups (P > 0.05).
293
Effects of the Ax treatment on ROS and CTSB activities 294 ROS and CTSB activities in IVG oocytes were greater in the control group than in the Ax-295 treated group (P < 0.01; Fig. 3B ).
297
Effects of the Ax treatment before and after IVG on the nuclear maturation of IVG oocytes 298 and their subsequent development 299 No significant differences were noted between meiotic stages before IVM (Table 1) . Most of 300 IVG oocytes (approximately 90%) were arrested at GV stage regardless of Ax addition.
Ax group than in the control group (P = 0.05) and the percentage of oocytes progressed 303 beyond GVBD stage were higher in Ax-treated group than the control group (P < 0.05; Table   304 2). In vivo-grown oocytes showed higher maturation rate than both group of IVG oocytes 305 (Table 2) . No significant differences were noted in cleavage rates after IVF between the 306 groups (P > 0.05; Table 3 ), but cleavages rate in both IVG groups were lower than that in in Namekawa et al. (2010) reported that the improving effects of Ax appeared to be due to its Furthermore, the inhibition of P4 production without the suppression of E2 production 413 between days 8 to 12 of IVG culture suggests that the luteinization of granulosa cells during 414 IVG cultures is inhibited by the antioxidative effects of Ax. Further investigation is needed 415 to clarify the function of Ax on steroidogenesis during IVG. Values are mean ± S.D. 650
Percentages of blastocysts are based on inseminated oocytes. 651 abc Different superscripts within a column indicate a significant difference between groups (P < 0.05). 
